{"nctId":"NCT01376388","briefTitle":"Long-term Safety Study for GSK573719/GW642444 in Japanese","startDateStruct":{"date":"2011-08"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"count":131,"armGroups":[{"label":"GSK573719/GW642444","type":"EXPERIMENTAL","interventionNames":["Drug: GSK573719/GW642444 Inhalation Powder"]}],"interventions":[{"name":"GSK573719/GW642444 Inhalation Powder","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Outpatient.\n* A signed and dated written informed consent prior to study participation.\n* Japanese subjects 40 years of age or older at screening.\n* Male or female subjects (female subjects who have child bearing potential has a negative pregnancy test at screening, and agrees to one of the acceptable contraceptive methods used consistently and correctly).\n* Diagnosis of COPD.\n* 10 pack-year or greater history of cigarette smoking.\n* Post-bronchodilator FEV1/FVC of \\<0.7.\n* Predicted FEV1 of \\<80%.\n\nExclusion Criteria:\n\n* Women who are pregnant or lactating or are planning on becoming pregnant during the study.\n* A current diagnosis of asthma.\n* Respiratory disorders other than COPD.\n* Clinically significant non-respiratory diseases or abnormalities that are not adequate controlled.\n* A chest X-ray or computed tomography (CT) scan that reveals evidence of clinically significant abnormalities not believed to be due to the presence of COPD.\n* A history of allergy or hypersensitivity to any anticholinergic/muscarinic receptor antagonist, beta2-agonist, lactose/milk protein or magnesium stearate or a medical condition.\n* Hospitalization for COPD or pneumonia within 12 weeks prior to screening.\n* Subjects with lung volume reduction surgery within the 12 months prior to screening.\n* Abnormal and clinically significant ECG findings at screening.\n* Significantly abnormal finding from clinical chemistry or hematology, tests at screening.\n* Use of long-term oxygen therapy (LTOT) described as oxygen therapy prescribed for greater than 12 hours a day.\n* Regular use (prescribed every day, not for as-needed use) of short-acting bronchodilators via nebulized therapy.\n* Participation in the acute phase of a pulmonary rehabilitation program within 4 weeks prior to screening.\n* A know or suspected history of alcohol or drug abuse within 2 years prior to screening.\n* Affiliation with the investigational site.\n* Previous use of GSK573719, GW642444, the GSK573719/GW642444 combination or the Fluticasone Furoate/GW642444 combination.\n* Use of any other investigational medication within 30 days or 5 drug half-lives (whichever is longer).","healthyVolunteers":false,"sex":"ALL","minimumAge":"40 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Any Adverse Event (AE) and Any Serious Adverse Event (SAE) Throughout the Treatment Period","description":"An AE is defined as any untoward medical occurrence in a clinical investigation participant, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a medicinal product. An SAE is defined as any untoward medical occurrence that, at any dose, results in death, is life threatening, requires hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect, may jeopardize the participant or may require medical or surgical intervention to prevent one of the other outcomes listed in this definition, or is an event of possible drug-induced liver injury. Refer to the general AE/SAE module for a list of AEs (occuring at a frequency threshold of \\>=5%) and SAEs.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"113","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Participants With AEs Classified by the Indicated Maximum Grade Throughout the Treatment Period","description":"An AE is defined as any untoward medical occurrence in a clinical investigation participant, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a medicinal product. AEs were classified according to intensity based upon the investigators' clinical judgment. The intensity was categorized as: mild (an event that is easily tolerated by the participant, causing minimal discomfort and not interfering with everyday activities); moderate (an event that is sufficiently discomforting to interfere with normal everyday activities); or severe (an event that prevents normal everyday activities).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"83","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null}]}]}]},{"type":"SECONDARY","title":"Basophil, Eosinophil, Lymphocyte, Monocyte, and Total Neutrophil Values at Baseline (BL; Week -2), Week 12, Week 24, Week 52, the Withdrawal (WD) Visit, Week 24/WD, and Week 52/WD","description":"Blood samples were collected for the measurement of the indicated laboratory parameters at following time points: BL (Week -2), Week 12, Week 24, Week 52, WD Visit (conducted for participants who withdrew at any point during the study), Week 24/WD (conducted for participants who completed the Week 24 visit or withdrew before Week 24), and Week 52/WD (conducted for participants who completed the Week 52 visit or withdrew before Week 52). The Baseline value for clinical laboratory tests was the value recorded on Week -2 (Screening visit).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.54","spread":"0.340"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.58","spread":"0.424"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.59","spread":"0.386"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.60","spread":"0.615"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.35","spread":"0.246"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.58","spread":"0.382"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.58","spread":"0.597"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.90","spread":"3.752"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.73","spread":"3.178"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.07","spread":"4.694"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.54","spread":"2.936"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.10","spread":"1.662"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.97","spread":"4.593"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.42","spread":"2.876"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29.07","spread":"8.471"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.48","spread":"7.703"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.40","spread":"8.620"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.71","spread":"7.906"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.28","spread":"8.110"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.12","spread":"8.636"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.10","spread":"8.150"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.15","spread":"1.758"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.33","spread":"1.727"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.27","spread":"1.541"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.20","spread":"1.827"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.44","spread":"1.290"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.32","spread":"1.541"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.30","spread":"1.818"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"60.34","spread":"9.047"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"60.88","spread":"8.880"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"60.67","spread":"9.595"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"60.96","spread":"8.714"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"68.83","spread":"8.296"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"61.01","spread":"9.538"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"61.60","spread":"8.915"}]}]}]},{"type":"SECONDARY","title":"Eosinophil Values, Total Neutrophil Values, Platelet Count, and White Blood Cell (WBC) Count at Baseline (BL; Week -2), Week 12, Week 24, Week 52, the Withdrawal (WD) Visit, Week 24/WD, and Week 52/WD","description":"Blood samples were collected for the measurment of the indicated laboratory parameters at the following time points: BL (Week -2), Week 12, Week 24, Week 52, WD Visit (conducted for participants who withdrew at any point during the study), Week 24/WD (conducted for participants who completed the Week 24 visit or withdrew before Week 24), and Week 52/WD (conducted for participants who completed the Week 52 visit or withdrew before Week 52). The Baseline value for clinical laboratory tests was the value recorded on Week -2 (Screening visit).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.245","spread":"0.2324"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.225","spread":"0.1815"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.260","spread":"0.3243"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.219","spread":"0.1992"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.135","spread":"0.1031"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.254","spread":"0.3171"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.212","spread":"0.1942"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.874","spread":"1.2587"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.798","spread":"1.2169"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.946","spread":"1.5517"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.899","spread":"1.5434"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.860","spread":"2.0869"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.953","spread":"1.5326"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.978","spread":"1.6060"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"234.3","spread":"54.92"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"238.6","spread":"56.35"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"239.3","spread":"59.54"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"233.8","spread":"58.63"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"232.0","spread":"84.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"240.0","spread":"60.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"233.6","spread":"60.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.38","spread":"1.588"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.18","spread":"1.443"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.39","spread":"1.803"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.30","spread":"1.892"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.88","spread":"2.203"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.37","spread":"1.778"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.35","spread":"1.916"}]}]}]},{"type":"SECONDARY","title":"Hemoglobin, Albumin, and Total Protein Values at Baseline (BL; Week -2), Week 12, Week 24, Week 52, the Withdrawal (WD) Visit, Week 24/WD, and Week 52/Withdrawal (WD)","description":"Blood samples were collected for the measurement of hemoglobin, albumin, and total protein at the following time points: BL (Week -2), Week 12, Week 24, Week 52, WD Visit (conducted for participants who withdrew at any point during the study), Week 24/WD (conducted for participants who completed the Week 24 visit or withdrew before Week 24), and Week 52/WD (conducted for participants who completed the Week 52 visit or withdrew before Week 52). The Baseline value for clinical laboratory tests was the value recorded on Week -2 (Screening visit).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"145.1","spread":"13.35"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"148.2","spread":"13.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"148.1","spread":"13.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"148.2","spread":"14.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"146.6","spread":"12.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"148.0","spread":"13.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"148.0","spread":"13.88"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.5","spread":"2.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.9","spread":"2.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.4","spread":"2.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.9","spread":"2.96"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.3","spread":"3.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.3","spread":"2.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.9","spread":"3.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70.9","spread":"4.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.8","spread":"4.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.2","spread":"4.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70.8","spread":"4.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"68.7","spread":"5.46"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.0","spread":"4.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70.6","spread":"4.85"}]}]}]},{"type":"SECONDARY","title":"Hematocrit Values at Baseline (BL; Week -2), Week 12, Week 24, Week 52, the Withdrawal (WD) Visit, Week 24/WD, and Week 52/WD","description":"Blood samples were collected for the measurement of hematocrit at the following time points: BL (Week -2), Week 12, Week 24, Week 52, WD Visit (conducted for participants who withdrew at any point during the study), Week 24/WD (conducted for participants who completed the Week 24 visit or withdrew before Week 24), and Week 52/WD (conducted for participants who completed the Week 52 visit or withdrew before Week 52). The Baseline value for clinical laboratory tests was the value recorded on Week -2 (Screening visit).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4460","spread":"0.03857"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4534","spread":"0.03575"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4515","spread":"0.03720"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4517","spread":"0.04063"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4473","spread":"0.03970"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4512","spread":"0.03724"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4513","spread":"0.04041"}]}]}]},{"type":"SECONDARY","title":"Alkaline Phosphatase (AP), Alanine Amino Transferase (ALT), Aspartate Amino Transferase (AST), Creatine Kinase, and Gamma Glutamyl Transferase (GGT) Values at Baseline (BL; Week -2), Week 12, Week 24, Week 52, the WD Visit, Week 24/WD, and Week 52/WD","description":"Blood samples were collected for the measurement of the indicated laboratory parameters at the following time points: BL (Week -2), Week 12, Week 24, Week 52, WD Visit (conducted for participants who withdrew at any point during the study), Week 24/WD (conducted for participants who completed the Week 24 visit or withdrew before Week 24), and Week 52/WD (conducted for participants who completed the Week 52 visit or withdrew before Week 52). The Baseline value for clinical laboratory tests was the value recorded on Week -2 (Screening visit).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"242.1","spread":"80.70"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"250.2","spread":"82.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"257.3","spread":"81.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"247.5","spread":"77.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"227.7","spread":"74.24"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"254.2","spread":"80.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"245.9","spread":"77.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.0","spread":"10.42"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.9","spread":"13.19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.8","spread":"13.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.2","spread":"12.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"31.7","spread":"28.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.1","spread":"13.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"22.0","spread":"14.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.4","spread":"7.35"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"25.0","spread":"8.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.9","spread":"9.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24.3","spread":"8.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.1","spread":"42.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24.7","spread":"14.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"25.7","spread":"15.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"114.1","spread":"59.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"120.3","spread":"111.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100.8","spread":"42.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"111.3","spread":"59.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"387.5","spread":"971.63"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124.0","spread":"271.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"134.0","spread":"281.54"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"47.1","spread":"54.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"49.1","spread":"57.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"49.1","spread":"63.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.9","spread":"78.30"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"46.3","spread":"26.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"49.2","spread":"61.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.3","spread":"75.37"}]}]}]},{"type":"SECONDARY","title":"Direct Bilirubin, Indirect Bilirubin, Total Bilirubin, Creatinine, and Uric Acid Values at Baseline (BL; Week -2), Week 12, Week 24, Week 52, the WD Visit, Week 24/WD, and Week 52/WD","description":"Blood samples were collected for the measuremnt of the indicated laboratory parameters at the following time points: BL (Week -2), Week 12, Week 24, Week 52, WD Visit (conducted for participants who withdrew at any point during the study), Week 24/WD (conducted for participants who completed the Week 24 visit or withdrew before Week 24), and Week 52/WD (conducted for participants who completed the Week 52 visit or withdrew before Week 52). The Baseline value for clinical laboratory tests was the value recorded on Week -2 (Screening visit).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.736","spread":"1.7659"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.514","spread":"1.6731"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.350","spread":"1.4975"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.680","spread":"1.6426"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.249","spread":"0.5407"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.340","spread":"1.4632"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.644","spread":"1.5846"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.064","spread":"2.8991"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.975","spread":"2.7725"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.728","spread":"2.5424"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.008","spread":"2.9302"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.985","spread":"2.4517"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.641","spread":"2.5348"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.924","spread":"2.8987"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.799","spread":"4.3585"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.489","spread":"4.1067"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.078","spread":"3.6643"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.687","spread":"4.2603"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.234","spread":"2.8156"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.982","spread":"3.6261"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.568","spread":"4.1714"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.3036","spread":"19.60971"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.3047","spread":"19.32910"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.2633","spread":"18.90496"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.6609","spread":"18.69402"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.8692","spread":"10.60022"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.2692","spread":"18.55960"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.3501","spread":"18.16682"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"357.8408","spread":"81.73895"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"353.2737","spread":"81.17581"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"348.2993","spread":"80.93244"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"353.2687","spread":"89.55111"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"343.7944","spread":"87.40840"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"349.1799","spread":"80.95415"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"352.4921","spread":"89.06027"}]}]}]},{"type":"SECONDARY","title":"Calcium, Chloride, Glucose, Carbon Dioxide/Bicarbonate (CO2/HCO3), Potassium, Sodium, Phosphorous Inorganic, and Urea/Blood Urea Nitrogen (Urea/BUN) Values at Baseline (BL; Week -2), Week 12, Week 24, Week 52, WD Visit, Week 24/WD, and Week 52/WD","description":"Blood samples were collected for the measurement of the indicated laboratory parameters at the following time points: BL (Week -2), Week 12, Week 24, Week 52, WD Visit (conducted for participants who withdrew at any point during the study), Week 24/WD (conducted for participants who completed the Week 24 visit or withdrew before Week 24), and Week 52/WD (conducted for participants who completed the Week 52 visit or withdrew before Week 52). The Baseline value for clinical laboratory tests was the value recorded on Week -2 (Screening visit).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.2954","spread":"0.09315"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.2948","spread":"0.09903"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.2837","spread":"0.09096"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.2765","spread":"0.09993"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.2829","spread":"0.15878"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.2842","spread":"0.09439"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.2770","spread":"0.10506"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"103.7","spread":"2.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"105.7","spread":"2.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"105.7","spread":"2.70"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"105.5","spread":"2.93"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"104.2","spread":"3.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"105.6","spread":"2.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"105.4","spread":"3.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.4447","spread":"1.86640"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.3343","spread":"1.63238"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.7313","spread":"2.20449"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.6325","spread":"1.81891"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.5280","spread":"1.52070"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.7085","spread":"2.15445"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.6239","spread":"1.79105"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"25.7","spread":"2.32"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"25.1","spread":"2.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24.1","spread":"2.31"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.8","spread":"2.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24.3","spread":"3.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24.2","spread":"2.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.9","spread":"2.30"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.29","spread":"0.380"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.34","spread":"0.384"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.33","spread":"0.374"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.31","spread":"0.362"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.42","spread":"0.301"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.33","spread":"0.366"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.32","spread":"0.357"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"141.4","spread":"2.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"142.3","spread":"1.95"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"142.3","spread":"2.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"141.4","spread":"2.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"140.4","spread":"3.72"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"142.2","spread":"2.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"141.4","spread":"2.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9714","spread":"0.15901"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0124","spread":"0.16447"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9975","spread":"0.16216"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9448","spread":"0.16492"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9913","spread":"0.17558"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9985","spread":"0.16349"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9486","spread":"0.16555"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.2660","spread":"1.52578"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.4764","spread":"1.80029"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.4998","spread":"1.50802"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.4570","spread":"1.66582"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.4335","spread":"2.05521"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.4856","spread":"1.52903"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.4551","spread":"1.69111"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Blood Pressure","description":"Blood pressure measurements included systolic blood pressure (SBP) and diastolic blood pressure (DBP). Blood pressure was measured in a sitting position after the participant was kept at rest for at least 5 minutes. Change from Baseline was calculated as the assessment value at the time of interest minus the Baseline value. The WD visit was conducted for participants who withdrew at any point during the study. The Week 24/WD visit was conducted for participants who completed the Week 24 visit or withdrew before Week 24. The Week 52/WD visit was conducted for participants who completed the Week 52 visit or withdrew before Week 52.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"12.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0","spread":"13.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":"13.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.7","spread":"14.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.3","spread":"13.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"13.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.3","spread":"18.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":"15.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2","spread":"14.19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":"9.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":"9.99"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"10.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"10.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.5","spread":"11.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"10.23"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.0","spread":"11.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"10.92"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"10.28"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Heart Rate","description":"Heart rate was measured in a sitting position after the participant was kept at rest for at least 5 minutes. Change from Baseline was calculated as the assessment value at the time of interest minus the Baseline value. The WD visit was conducted for participants who withdrew at any point during the study. The Week 24/WD visit was conducted for participants who completed the Week 24 visit or withdrew before Week 24. The Week 52/WD visit was conducted for participants who completed the Week 52 visit or withdrew before Week 52.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.7","spread":"10.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.7","spread":"9.39"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.4","spread":"10.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.5","spread":"10.63"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.2","spread":"10.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.7","spread":"10.63"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.0","spread":"10.46"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.1","spread":"10.67"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1","spread":"10.90"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Abnormal 12-lead Electrocardiogram (ECG) Findings at the Indicated Time Points","description":"A 12-lead ECG was recorded in a supine position after the participant was kept at rest in this position for at least 5 minutes. Data are presented as clinically significant (CS) or not clinically significant (NCS) abnormal findings. An abnormal and significant ECG finding includes the presence of a QT interval corrected for heart rate (QTc interval) \\>500 milliseconds (msec) or an uncorrected QT interval \\>600 msec, for participants with Bundle Branch Block QTc \\>530 msec based on an average QTc value of triplicate ECGs. The study investigator determined if the abnormal ECG finding was CS or NCS. The WD visit was conducted for participants who withdrew at any point during the study. The Week 24/WD and Week 52/WD visits were conducted for participants who completed the Week 24 visit or withdrew before Week 24 and completed the Week 52 visit or withdrew before Week 52, respectively. The Baseline value for clinical laboratory tests was the value recorded on Week -2 (Screening visit).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"47","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"46","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"51","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":16,"n":130},"commonTop":["Nasopharyngitis","Bronchitis","Pharyngitis","Constipation"]}}}